These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6703924)

  • 1. A perfluorochemical emulsion as an oxygen carrier.
    Yokoyama K; Suyama T; Okamoto H; Watanabe M; Ohyanagi H; Saitoh Y
    Artif Organs; 1984 Feb; 8(1):34-40. PubMed ID: 6703924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a perfluorochemical emulsion as a blood gas carrier.
    Mitsuno T; Ohyanagi H; Yokoyama K
    Artif Organs; 1984 Feb; 8(1):25-33. PubMed ID: 6422912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of 53 PFC substances for better stability of emulsion and improved artificial blood substitutes.
    Yokoyama K; Naito R; Tsuda Y; Fukaya C; Watanabe M; Hanada S; Suyama T
    Prog Clin Biol Res; 1983; 122():189-96. PubMed ID: 6878360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility studies with a novel perfluorochemical emulsion.
    Bollands AD; Lowe KC; Sharma SK; Davis SS
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):451-3. PubMed ID: 3179482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen-transport fluid based on perfluorochemicals: effects on liver biochemistry.
    Lowe KC; Armstrong FH
    Adv Exp Med Biol; 1990; 277():267-76. PubMed ID: 2096632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular behavior of a perfluorochemical emulsion.
    Tsuda Y; Yamanouchi K; Okamoto H; Yokoyama K; Heldebrant C
    J Pharmacobiodyn; 1990 Mar; 13(3):165-71. PubMed ID: 2374085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half life and changes in the composition of a perfluorochemical emulsion within the vascular system of rats.
    Lutz J; Stark M
    Pflugers Arch; 1987 Sep; 410(1-2):181-4. PubMed ID: 3684504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
    Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
    Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid tissue responses to emulsified perfluorochemicals: comparative aspects.
    Lowe KC; Bollands AD
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):495-504. PubMed ID: 3179486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a perfluorochemical emulsion on the rat hepatic mixed function oxidase system.
    Ravis WR; Ramakanth S; Brzozowski DM; Hamrick ME
    J Pharm Pharmacol; 1992 Mar; 44(3):219-23. PubMed ID: 1354727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a perfluorocarbon emulsion, Fluosol-DA, on rat lymphoid tissue and immunological competence.
    Bollands AD; Lowe KC
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 85(2):309-12. PubMed ID: 2879690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfluorodecalin emulsion tested for biocompatibility in macrophages by means of a magnetometric method.
    Koester M; Lutz J; Augustin AJ; Meinert H
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1231-6. PubMed ID: 7849927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of a 35% fluorocarbon emulsion.
    Gould SA; Sehgal LR; Rosen AL; Langdale LA; Sehgal HL; Krause L; Moss GS
    J Trauma; 1983 Aug; 23(8):720-4. PubMed ID: 6887290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat.
    Shrewsbury RP; White SG; Pollack GM; Wargin WA
    J Pharm Pharmacol; 1986 Dec; 38(12):883-7. PubMed ID: 2880960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of emulsified perfluorochemicals on liver cytochromes P-450 in rats.
    Armstrong FH; Lowe KC
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 94(1):345-9. PubMed ID: 2576743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorochemical blood substitutes differentially alter human monocyte procoagulant generation and oxidative metabolism.
    Janco RL; Virmani R; Morris PJ; Gunter K
    Transfusion; 1985; 25(6):578-82. PubMed ID: 4071604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increases in brain tumor and cerebral blood flow by blood-perfluorochemical emulsion (Fluosol-DA) exchange.
    Hiraga S; Klubes P; Owens ES; Cysyk RL; Blasberg RG
    Cancer Res; 1987 Jun; 47(12):3296-302. PubMed ID: 3581070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in intravascular fluid composition following blood replacement with perfluorocarbon emulsion in the rat.
    Lowe KC; McNaughton DC; Hardy RN
    Klin Wochenschr; 1985 Oct; 63(19):1028-34. PubMed ID: 4068605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
    Watanabe M; Okamoto H; Ohyanaqi H; Saitoh Y; Yano K; Tsuda Y; Ueda Y; Yokoyama K
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):547-56. PubMed ID: 3140922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S; Handa H; Naruo Y; Oda Y; Yonekawa Y; Takebe Y
    Neurol Res; 1981; 3(3):237-50. PubMed ID: 6122175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.